AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Natural Alternatives shares rise 14.59% premarket on 13.8% sales growth and improved Q1 profitability.
ByAinvest
Thursday, Nov 13, 2025 9:24 am ET1min read
Natural Alternatives International (NAII) surged 14.59% in premarket trading following the release of its Q1 2026 financial results, which highlighted a 13.8% year-over-year increase in net sales to $37.7 million, driven by a 17.7% rise in private-label contract manufacturing revenue. Despite a 33.9% decline in CarnoSyn® beta-alanine revenue, the company reported a narrowed net loss of $0.3 million (from $2.0 million) and generated income from operations for the first time in the quarter. CEO Mark Le Doux emphasized improved factory utilization, new customer growth, and the potential of TriBsyn™ in addressing healthcare trends linked to GLP-1 medications, while reaffirming guidance for full-year profitability. The upbeat results and forward-looking optimism aligned with the stock’s sharp premarket rally.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet